Protein A Resin Comprehensive Study by Type (Natural Protein A, Recombinant Protein A), Application (Immunoprecipitation, Antibody Purification), Matrix (Glass or Silica Gel-based Matrix, Agarose-based Matrix), End User (Biopharmaceutical, Clinical Research, Others) Players and Region - Global Market Outlook to 2026

Protein A Resin Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Protein A Resin is a technique for the separation and purification of classes and subclasses of fragmented protein from biological fluids like blood, plasma, urine, etc. and monoclonal antibodies which are the laboratory-produced molecules to work as a substitute antibodies which can perform the function like restoration and enhance or mimic the immune system's attack on cancer cells.

Market Drivers
  • Increasing Prevalence of Cancer and Other Chronic Diseases
  • Rising Research and Development Activities


Restraints
  • High Cost of Protein A Resin can be the Hindrance for the Market
  • Complexities Involved with Production of Protein A Resin


The Protein A Resin market framework should serve as a basic structure to support the strategic decision-making process for Players. For instance, the question of whether a Players wants to expand in other areas of the market value chain would fundamentally determines its strategy.

ƒ What is the current setup of the Protein A Resin Industry, and what is its growth trajectory through 2026?
ƒ Trends that might impact the resulting strategic moves of the Players
ƒ How can Players take advantage of the changing market dynamics and capture new opportunities lying in Protein A Resin market?

The key Players profiled in the report are GE Healthcare (United States), Thermo Fisher Scientific (United States), Repligen Corporation (United States), Merck Millipore (United States), Tosoh Bioscience (Japan), Novasep Inc. (France), GenScript Biotech (United States), Expedeon (United Kingdom) and Purolite Corporation (United States).

Report Objectives / Segmentation Covered

By Type
  • Natural Protein A
  • Recombinant Protein A
By Application
  • Immunoprecipitation
  • Antibody Purification
By Matrix
  • Glass or Silica Gel-based Matrix
  • Agarose-based Matrix

By End User
  • Biopharmaceutical
  • Clinical Research
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Cancer and Other Chronic Diseases
      • 3.2.2. Rising Research and Development Activities
    • 3.3. Market Challenges
      • 3.3.1. Problems with Storage and Degradation of Protein A Resin
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Protein A Resin, by Type, Application, Matrix, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Protein A Resin (Value)
      • 5.2.1. Global Protein A Resin by: Type (Value)
        • 5.2.1.1. Natural Protein A
        • 5.2.1.2. Recombinant Protein A
      • 5.2.2. Global Protein A Resin by: Application (Value)
        • 5.2.2.1. Immunoprecipitation
        • 5.2.2.2. Antibody Purification
      • 5.2.3. Global Protein A Resin by: Matrix (Value)
        • 5.2.3.1. Glass or Silica Gel-based Matrix
        • 5.2.3.2. Agarose-based Matrix
      • 5.2.4. Global Protein A Resin by: End User (Value)
        • 5.2.4.1. Biopharmaceutical
        • 5.2.4.2. Clinical Research
        • 5.2.4.3. Others
      • 5.2.5. Global Protein A Resin Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Protein A Resin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Repligen Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck Millipore (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Tosoh Bioscience (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novasep Inc. (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GenScript Biotech (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Expedeon (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Purolite Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Protein A Resin Sale, by Type, Application, Matrix, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Protein A Resin (Value)
      • 7.2.1. Global Protein A Resin by: Type (Value)
        • 7.2.1.1. Natural Protein A
        • 7.2.1.2. Recombinant Protein A
      • 7.2.2. Global Protein A Resin by: Application (Value)
        • 7.2.2.1. Immunoprecipitation
        • 7.2.2.2. Antibody Purification
      • 7.2.3. Global Protein A Resin by: Matrix (Value)
        • 7.2.3.1. Glass or Silica Gel-based Matrix
        • 7.2.3.2. Agarose-based Matrix
      • 7.2.4. Global Protein A Resin by: End User (Value)
        • 7.2.4.1. Biopharmaceutical
        • 7.2.4.2. Clinical Research
        • 7.2.4.3. Others
      • 7.2.5. Global Protein A Resin Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Protein A Resin: by Type(USD Million)
  • Table 2. Protein A Resin Natural Protein A , by Region USD Million (2015-2020)
  • Table 3. Protein A Resin Recombinant Protein A , by Region USD Million (2015-2020)
  • Table 4. Protein A Resin: by Application(USD Million)
  • Table 5. Protein A Resin Immunoprecipitation , by Region USD Million (2015-2020)
  • Table 6. Protein A Resin Antibody Purification , by Region USD Million (2015-2020)
  • Table 7. Protein A Resin: by Matrix(USD Million)
  • Table 8. Protein A Resin Glass or Silica Gel-based Matrix , by Region USD Million (2015-2020)
  • Table 9. Protein A Resin Agarose-based Matrix , by Region USD Million (2015-2020)
  • Table 10. Protein A Resin: by End User(USD Million)
  • Table 11. Protein A Resin Biopharmaceutical , by Region USD Million (2015-2020)
  • Table 12. Protein A Resin Clinical Research , by Region USD Million (2015-2020)
  • Table 13. Protein A Resin Others , by Region USD Million (2015-2020)
  • Table 14. South America Protein A Resin, by Country USD Million (2015-2020)
  • Table 15. South America Protein A Resin, by Type USD Million (2015-2020)
  • Table 16. South America Protein A Resin, by Application USD Million (2015-2020)
  • Table 17. South America Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 18. South America Protein A Resin, by End User USD Million (2015-2020)
  • Table 19. Brazil Protein A Resin, by Type USD Million (2015-2020)
  • Table 20. Brazil Protein A Resin, by Application USD Million (2015-2020)
  • Table 21. Brazil Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 22. Brazil Protein A Resin, by End User USD Million (2015-2020)
  • Table 23. Argentina Protein A Resin, by Type USD Million (2015-2020)
  • Table 24. Argentina Protein A Resin, by Application USD Million (2015-2020)
  • Table 25. Argentina Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 26. Argentina Protein A Resin, by End User USD Million (2015-2020)
  • Table 27. Rest of South America Protein A Resin, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Protein A Resin, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 30. Rest of South America Protein A Resin, by End User USD Million (2015-2020)
  • Table 31. Asia Pacific Protein A Resin, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Protein A Resin, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Protein A Resin, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 35. Asia Pacific Protein A Resin, by End User USD Million (2015-2020)
  • Table 36. China Protein A Resin, by Type USD Million (2015-2020)
  • Table 37. China Protein A Resin, by Application USD Million (2015-2020)
  • Table 38. China Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 39. China Protein A Resin, by End User USD Million (2015-2020)
  • Table 40. Japan Protein A Resin, by Type USD Million (2015-2020)
  • Table 41. Japan Protein A Resin, by Application USD Million (2015-2020)
  • Table 42. Japan Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 43. Japan Protein A Resin, by End User USD Million (2015-2020)
  • Table 44. India Protein A Resin, by Type USD Million (2015-2020)
  • Table 45. India Protein A Resin, by Application USD Million (2015-2020)
  • Table 46. India Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 47. India Protein A Resin, by End User USD Million (2015-2020)
  • Table 48. South Korea Protein A Resin, by Type USD Million (2015-2020)
  • Table 49. South Korea Protein A Resin, by Application USD Million (2015-2020)
  • Table 50. South Korea Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 51. South Korea Protein A Resin, by End User USD Million (2015-2020)
  • Table 52. Taiwan Protein A Resin, by Type USD Million (2015-2020)
  • Table 53. Taiwan Protein A Resin, by Application USD Million (2015-2020)
  • Table 54. Taiwan Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 55. Taiwan Protein A Resin, by End User USD Million (2015-2020)
  • Table 56. Australia Protein A Resin, by Type USD Million (2015-2020)
  • Table 57. Australia Protein A Resin, by Application USD Million (2015-2020)
  • Table 58. Australia Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 59. Australia Protein A Resin, by End User USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Protein A Resin, by Type USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Protein A Resin, by Application USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Protein A Resin, by End User USD Million (2015-2020)
  • Table 64. Europe Protein A Resin, by Country USD Million (2015-2020)
  • Table 65. Europe Protein A Resin, by Type USD Million (2015-2020)
  • Table 66. Europe Protein A Resin, by Application USD Million (2015-2020)
  • Table 67. Europe Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 68. Europe Protein A Resin, by End User USD Million (2015-2020)
  • Table 69. Germany Protein A Resin, by Type USD Million (2015-2020)
  • Table 70. Germany Protein A Resin, by Application USD Million (2015-2020)
  • Table 71. Germany Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 72. Germany Protein A Resin, by End User USD Million (2015-2020)
  • Table 73. France Protein A Resin, by Type USD Million (2015-2020)
  • Table 74. France Protein A Resin, by Application USD Million (2015-2020)
  • Table 75. France Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 76. France Protein A Resin, by End User USD Million (2015-2020)
  • Table 77. Italy Protein A Resin, by Type USD Million (2015-2020)
  • Table 78. Italy Protein A Resin, by Application USD Million (2015-2020)
  • Table 79. Italy Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 80. Italy Protein A Resin, by End User USD Million (2015-2020)
  • Table 81. United Kingdom Protein A Resin, by Type USD Million (2015-2020)
  • Table 82. United Kingdom Protein A Resin, by Application USD Million (2015-2020)
  • Table 83. United Kingdom Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 84. United Kingdom Protein A Resin, by End User USD Million (2015-2020)
  • Table 85. Netherlands Protein A Resin, by Type USD Million (2015-2020)
  • Table 86. Netherlands Protein A Resin, by Application USD Million (2015-2020)
  • Table 87. Netherlands Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 88. Netherlands Protein A Resin, by End User USD Million (2015-2020)
  • Table 89. Rest of Europe Protein A Resin, by Type USD Million (2015-2020)
  • Table 90. Rest of Europe Protein A Resin, by Application USD Million (2015-2020)
  • Table 91. Rest of Europe Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 92. Rest of Europe Protein A Resin, by End User USD Million (2015-2020)
  • Table 93. MEA Protein A Resin, by Country USD Million (2015-2020)
  • Table 94. MEA Protein A Resin, by Type USD Million (2015-2020)
  • Table 95. MEA Protein A Resin, by Application USD Million (2015-2020)
  • Table 96. MEA Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 97. MEA Protein A Resin, by End User USD Million (2015-2020)
  • Table 98. Middle East Protein A Resin, by Type USD Million (2015-2020)
  • Table 99. Middle East Protein A Resin, by Application USD Million (2015-2020)
  • Table 100. Middle East Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 101. Middle East Protein A Resin, by End User USD Million (2015-2020)
  • Table 102. Africa Protein A Resin, by Type USD Million (2015-2020)
  • Table 103. Africa Protein A Resin, by Application USD Million (2015-2020)
  • Table 104. Africa Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 105. Africa Protein A Resin, by End User USD Million (2015-2020)
  • Table 106. North America Protein A Resin, by Country USD Million (2015-2020)
  • Table 107. North America Protein A Resin, by Type USD Million (2015-2020)
  • Table 108. North America Protein A Resin, by Application USD Million (2015-2020)
  • Table 109. North America Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 110. North America Protein A Resin, by End User USD Million (2015-2020)
  • Table 111. United States Protein A Resin, by Type USD Million (2015-2020)
  • Table 112. United States Protein A Resin, by Application USD Million (2015-2020)
  • Table 113. United States Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 114. United States Protein A Resin, by End User USD Million (2015-2020)
  • Table 115. Canada Protein A Resin, by Type USD Million (2015-2020)
  • Table 116. Canada Protein A Resin, by Application USD Million (2015-2020)
  • Table 117. Canada Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 118. Canada Protein A Resin, by End User USD Million (2015-2020)
  • Table 119. Mexico Protein A Resin, by Type USD Million (2015-2020)
  • Table 120. Mexico Protein A Resin, by Application USD Million (2015-2020)
  • Table 121. Mexico Protein A Resin, by Matrix USD Million (2015-2020)
  • Table 122. Mexico Protein A Resin, by End User USD Million (2015-2020)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Protein A Resin: by Type(USD Million)
  • Table 133. Protein A Resin Natural Protein A , by Region USD Million (2021-2026)
  • Table 134. Protein A Resin Recombinant Protein A , by Region USD Million (2021-2026)
  • Table 135. Protein A Resin: by Application(USD Million)
  • Table 136. Protein A Resin Immunoprecipitation , by Region USD Million (2021-2026)
  • Table 137. Protein A Resin Antibody Purification , by Region USD Million (2021-2026)
  • Table 138. Protein A Resin: by Matrix(USD Million)
  • Table 139. Protein A Resin Glass or Silica Gel-based Matrix , by Region USD Million (2021-2026)
  • Table 140. Protein A Resin Agarose-based Matrix , by Region USD Million (2021-2026)
  • Table 141. Protein A Resin: by End User(USD Million)
  • Table 142. Protein A Resin Biopharmaceutical , by Region USD Million (2021-2026)
  • Table 143. Protein A Resin Clinical Research , by Region USD Million (2021-2026)
  • Table 144. Protein A Resin Others , by Region USD Million (2021-2026)
  • Table 145. South America Protein A Resin, by Country USD Million (2021-2026)
  • Table 146. South America Protein A Resin, by Type USD Million (2021-2026)
  • Table 147. South America Protein A Resin, by Application USD Million (2021-2026)
  • Table 148. South America Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 149. South America Protein A Resin, by End User USD Million (2021-2026)
  • Table 150. Brazil Protein A Resin, by Type USD Million (2021-2026)
  • Table 151. Brazil Protein A Resin, by Application USD Million (2021-2026)
  • Table 152. Brazil Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 153. Brazil Protein A Resin, by End User USD Million (2021-2026)
  • Table 154. Argentina Protein A Resin, by Type USD Million (2021-2026)
  • Table 155. Argentina Protein A Resin, by Application USD Million (2021-2026)
  • Table 156. Argentina Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 157. Argentina Protein A Resin, by End User USD Million (2021-2026)
  • Table 158. Rest of South America Protein A Resin, by Type USD Million (2021-2026)
  • Table 159. Rest of South America Protein A Resin, by Application USD Million (2021-2026)
  • Table 160. Rest of South America Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 161. Rest of South America Protein A Resin, by End User USD Million (2021-2026)
  • Table 162. Asia Pacific Protein A Resin, by Country USD Million (2021-2026)
  • Table 163. Asia Pacific Protein A Resin, by Type USD Million (2021-2026)
  • Table 164. Asia Pacific Protein A Resin, by Application USD Million (2021-2026)
  • Table 165. Asia Pacific Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 166. Asia Pacific Protein A Resin, by End User USD Million (2021-2026)
  • Table 167. China Protein A Resin, by Type USD Million (2021-2026)
  • Table 168. China Protein A Resin, by Application USD Million (2021-2026)
  • Table 169. China Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 170. China Protein A Resin, by End User USD Million (2021-2026)
  • Table 171. Japan Protein A Resin, by Type USD Million (2021-2026)
  • Table 172. Japan Protein A Resin, by Application USD Million (2021-2026)
  • Table 173. Japan Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 174. Japan Protein A Resin, by End User USD Million (2021-2026)
  • Table 175. India Protein A Resin, by Type USD Million (2021-2026)
  • Table 176. India Protein A Resin, by Application USD Million (2021-2026)
  • Table 177. India Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 178. India Protein A Resin, by End User USD Million (2021-2026)
  • Table 179. South Korea Protein A Resin, by Type USD Million (2021-2026)
  • Table 180. South Korea Protein A Resin, by Application USD Million (2021-2026)
  • Table 181. South Korea Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 182. South Korea Protein A Resin, by End User USD Million (2021-2026)
  • Table 183. Taiwan Protein A Resin, by Type USD Million (2021-2026)
  • Table 184. Taiwan Protein A Resin, by Application USD Million (2021-2026)
  • Table 185. Taiwan Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 186. Taiwan Protein A Resin, by End User USD Million (2021-2026)
  • Table 187. Australia Protein A Resin, by Type USD Million (2021-2026)
  • Table 188. Australia Protein A Resin, by Application USD Million (2021-2026)
  • Table 189. Australia Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 190. Australia Protein A Resin, by End User USD Million (2021-2026)
  • Table 191. Rest of Asia-Pacific Protein A Resin, by Type USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific Protein A Resin, by Application USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Protein A Resin, by End User USD Million (2021-2026)
  • Table 195. Europe Protein A Resin, by Country USD Million (2021-2026)
  • Table 196. Europe Protein A Resin, by Type USD Million (2021-2026)
  • Table 197. Europe Protein A Resin, by Application USD Million (2021-2026)
  • Table 198. Europe Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 199. Europe Protein A Resin, by End User USD Million (2021-2026)
  • Table 200. Germany Protein A Resin, by Type USD Million (2021-2026)
  • Table 201. Germany Protein A Resin, by Application USD Million (2021-2026)
  • Table 202. Germany Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 203. Germany Protein A Resin, by End User USD Million (2021-2026)
  • Table 204. France Protein A Resin, by Type USD Million (2021-2026)
  • Table 205. France Protein A Resin, by Application USD Million (2021-2026)
  • Table 206. France Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 207. France Protein A Resin, by End User USD Million (2021-2026)
  • Table 208. Italy Protein A Resin, by Type USD Million (2021-2026)
  • Table 209. Italy Protein A Resin, by Application USD Million (2021-2026)
  • Table 210. Italy Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 211. Italy Protein A Resin, by End User USD Million (2021-2026)
  • Table 212. United Kingdom Protein A Resin, by Type USD Million (2021-2026)
  • Table 213. United Kingdom Protein A Resin, by Application USD Million (2021-2026)
  • Table 214. United Kingdom Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 215. United Kingdom Protein A Resin, by End User USD Million (2021-2026)
  • Table 216. Netherlands Protein A Resin, by Type USD Million (2021-2026)
  • Table 217. Netherlands Protein A Resin, by Application USD Million (2021-2026)
  • Table 218. Netherlands Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 219. Netherlands Protein A Resin, by End User USD Million (2021-2026)
  • Table 220. Rest of Europe Protein A Resin, by Type USD Million (2021-2026)
  • Table 221. Rest of Europe Protein A Resin, by Application USD Million (2021-2026)
  • Table 222. Rest of Europe Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 223. Rest of Europe Protein A Resin, by End User USD Million (2021-2026)
  • Table 224. MEA Protein A Resin, by Country USD Million (2021-2026)
  • Table 225. MEA Protein A Resin, by Type USD Million (2021-2026)
  • Table 226. MEA Protein A Resin, by Application USD Million (2021-2026)
  • Table 227. MEA Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 228. MEA Protein A Resin, by End User USD Million (2021-2026)
  • Table 229. Middle East Protein A Resin, by Type USD Million (2021-2026)
  • Table 230. Middle East Protein A Resin, by Application USD Million (2021-2026)
  • Table 231. Middle East Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 232. Middle East Protein A Resin, by End User USD Million (2021-2026)
  • Table 233. Africa Protein A Resin, by Type USD Million (2021-2026)
  • Table 234. Africa Protein A Resin, by Application USD Million (2021-2026)
  • Table 235. Africa Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 236. Africa Protein A Resin, by End User USD Million (2021-2026)
  • Table 237. North America Protein A Resin, by Country USD Million (2021-2026)
  • Table 238. North America Protein A Resin, by Type USD Million (2021-2026)
  • Table 239. North America Protein A Resin, by Application USD Million (2021-2026)
  • Table 240. North America Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 241. North America Protein A Resin, by End User USD Million (2021-2026)
  • Table 242. United States Protein A Resin, by Type USD Million (2021-2026)
  • Table 243. United States Protein A Resin, by Application USD Million (2021-2026)
  • Table 244. United States Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 245. United States Protein A Resin, by End User USD Million (2021-2026)
  • Table 246. Canada Protein A Resin, by Type USD Million (2021-2026)
  • Table 247. Canada Protein A Resin, by Application USD Million (2021-2026)
  • Table 248. Canada Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 249. Canada Protein A Resin, by End User USD Million (2021-2026)
  • Table 250. Mexico Protein A Resin, by Type USD Million (2021-2026)
  • Table 251. Mexico Protein A Resin, by Application USD Million (2021-2026)
  • Table 252. Mexico Protein A Resin, by Matrix USD Million (2021-2026)
  • Table 253. Mexico Protein A Resin, by End User USD Million (2021-2026)
  • Table 254. Research Programs/Design for This Report
  • Table 255. Key Data Information from Secondary Sources
  • Table 256. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Protein A Resin: by Type USD Million (2015-2020)
  • Figure 5. Global Protein A Resin: by Application USD Million (2015-2020)
  • Figure 6. Global Protein A Resin: by Matrix USD Million (2015-2020)
  • Figure 7. Global Protein A Resin: by End User USD Million (2015-2020)
  • Figure 8. South America Protein A Resin Share (%), by Country
  • Figure 9. Asia Pacific Protein A Resin Share (%), by Country
  • Figure 10. Europe Protein A Resin Share (%), by Country
  • Figure 11. MEA Protein A Resin Share (%), by Country
  • Figure 12. North America Protein A Resin Share (%), by Country
  • Figure 13. Global Protein A Resin share by Players 2020 (%)
  • Figure 14. Global Protein A Resin share by Players (Top 3) 2020(%)
  • Figure 15. Global Protein A Resin share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 18. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 21. Repligen Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Repligen Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Merck Millipore (United States) Revenue, Net Income and Gross profit
  • Figure 24. Merck Millipore (United States) Revenue: by Geography 2020
  • Figure 25. Tosoh Bioscience (Japan) Revenue, Net Income and Gross profit
  • Figure 26. Tosoh Bioscience (Japan) Revenue: by Geography 2020
  • Figure 27. Novasep Inc. (France) Revenue, Net Income and Gross profit
  • Figure 28. Novasep Inc. (France) Revenue: by Geography 2020
  • Figure 29. GenScript Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 30. GenScript Biotech (United States) Revenue: by Geography 2020
  • Figure 31. Expedeon (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Expedeon (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Purolite Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Purolite Corporation (United States) Revenue: by Geography 2020
  • Figure 35. Global Protein A Resin: by Type USD Million (2021-2026)
  • Figure 36. Global Protein A Resin: by Application USD Million (2021-2026)
  • Figure 37. Global Protein A Resin: by Matrix USD Million (2021-2026)
  • Figure 38. Global Protein A Resin: by End User USD Million (2021-2026)
  • Figure 39. South America Protein A Resin Share (%), by Country
  • Figure 40. Asia Pacific Protein A Resin Share (%), by Country
  • Figure 41. Europe Protein A Resin Share (%), by Country
  • Figure 42. MEA Protein A Resin Share (%), by Country
  • Figure 43. North America Protein A Resin Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Thermo Fisher Scientific (United States)
  • Repligen Corporation (United States)
  • Merck Millipore (United States)
  • Tosoh Bioscience (Japan)
  • Novasep Inc. (France)
  • GenScript Biotech (United States)
  • Expedeon (United Kingdom)
  • Purolite Corporation (United States)
Select User Access Type

Key Highlights of Report


Aug 2021 239 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Protein A Resin market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Protein A Resin market are GE Healthcare (United States), Thermo Fisher Scientific (United States), Repligen Corporation (United States), Merck Millipore (United States), Tosoh Bioscience (Japan), Novasep Inc. (France), GenScript Biotech (United States), Expedeon (United Kingdom) and Purolite Corporation (United States), to name a few.

Know More About Global Protein A Resin Market report Report?